The CRISPR craze: Applications and implications of genome editing technologies
Join us for this unique opportunity to meet Dr. Rodolphe Barrangou, Professor at North Carolina State University, whose research focus on the evolution and functions of CRISPR-Cas systems and their applications in bacteria used in food manufacturing.
In nature, CRISPR and associated Cas proteins constitute the CRISPR-Cas system, which provides adaptive immunity against invasive elements in many bacteria and most archaea. Recently, the CRISPR machinery has been repurposed to fuel the Cas9-enabled genome editing craze. Actually, the democratization of CRISPR-based technologies in the past six years hinges on the portability and functionalities of these molecular machines, and has revolutionized biology.
Rodolphe Barrangou will look back on the historical milestones that have paved the way for the CRISPR era, and discuss the diverse applications that have impacted and continue to shape the fields of Medicine, Ag, Food and Biotechnology. He will also discuss the impacts this transformative field has had on science and society, and address business implications of this disruptive technology.
Join IDA Bioscience for this opportunity to meet Dr. Barrangou during his visit to Denmark.
Program
15.30: Arrival and registration
16.00: Welcome by IDA Bioscience
16.10: The CRISPR craze by Dr. Rodolphe Barrangou
16.40: Break
17.00: The CRISPR craze – continued
17.30: Q&A with Dr. Barrangou
17.50: Wrap up
About Rodolphe Barrangou
Dr. Barrangou is the T. R. Klaenhammer Distinguished Professor in Probiotics Research in the Department of Food, Bioprocessing and Nutrition Sciences at North Carolina State University, focusing on the evolution and functions of CRISPR-Cas systems, and their applications in bacteria used in food manufacturing.
Dr. Barrangou spent 9 years in R&D and M&A at Danisco and DuPont in the Food Industry.
Recently, for his work establishing the biological function of CRISPR, Rodolphe received the 2016 Warren Alpert Prize, the 2016 Canada Gairdner International Award, the 2017 NAS Award in Molecular Biology and the 2018 NAS Prize in Food and Agriculture Sciences.
Dr. Barrangou is also the former Chairman of the Board of Directors of Caribou Biosciences, a co-founder and member of the Scientific Advisory Board of Intellia Therapeutics, a co-founder of Locus Biosciences, an advisor to Inari Ag, and the Editor in Chief of the CRISPR Journal.
This event is closed for registration.
Information